Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility
- PMID: 6972952
- PMCID: PMC370783
- DOI: 10.1172/jci110231
Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility
Abstract
During tuberculosis, exposure of monocytes to circulating factors may induce the suppressor activity observed in some anergic patients. To explore this possibility, we examined the effects of plasma pooled from 28 untreated tuberculosis (TB) patients and the mycobacterial cell wall polysaccharide D-arabino-D-galactan (AG) on the in vitro function of peripheral blood mononuclear cells (PBMC) from healthy donors. In the [3H] thymidine incorporation assay, stimulated responses of PBMC incubated in culture medium supplemented with TB plasma or co-cultured with 3.0 microgram/ml AG were depressed significantly when compared with control responses. Cytotoxicity and altered kinetics of stimulated DNA synthesis did not contribute to the observed suppression. TB plasma and AG-induced suppression of the PBMC response to purified protein derivative was monocyte dependent and indomethacin reversible. In addition, TB plasma and AG directly inhibited the phytohemagglutinin-stimulated responses of T lymphocytes. In a quantitative assay of monocyte attachment to plastic, both TB plasma and AG significantly increased monocyte adherence from basal levels. These effects on monocyte adherence were reversed with indomethacin or antibody to mycobacterial polysaccharide. In addition, TB plasma passed over an immunoabsorbent column of Sepharose-linked antibody to mycobacterial polysaccharide was depleted of the suppressive and monocyte-adherence augmenting factors. 3.0 microgram/ml AG stimulated a fivefold increase in prostaglandin E2 production by cultured mononuclear cells. Our data suggest that AG circulating alone or bound in immune complexes may account for the observed effects of TB plasma. Similar in vivo exposure may contribute to the cell-mediated suppression of lymphocyte responses in tuberculosis.
Similar articles
-
Immunologic aspects of mycobacterial infections.Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S455-9. doi: 10.1093/clinids/11.supplement_2.s455. Rev Infect Dis. 1989. PMID: 2469122 Review.
-
Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.J Immunol. 1982 Oct;129(4):1770-4. J Immunol. 1982. PMID: 6980949
-
Divergent T gamma cell functions in antigen-induced blastogenesis: facilitory interactions with Tnon gamma cells and participation in monocyte- and prostaglandin-mediated suppression.J Lab Clin Med. 1983 Nov;102(5):751-61. J Lab Clin Med. 1983. PMID: 6226756
-
Augmentation of selective monocyte functions in tuberculosis.J Infect Dis. 1981 Nov;144(5):391-8. doi: 10.1093/infdis/144.5.391. J Infect Dis. 1981. PMID: 6947016
-
Suppressor monocytes in human disease: a review.Adv Exp Med Biol. 1979;121B:283-98. doi: 10.1007/978-1-4684-8914-9_27. Adv Exp Med Biol. 1979. PMID: 161850 Review.
Cited by
-
Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.Dig Dis Sci. 2002 Mar;47(3):556-61. doi: 10.1023/a:1017911918332. Dig Dis Sci. 2002. PMID: 11911341
-
Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.J Exp Med. 1984 Jan 1;159(1):126-36. doi: 10.1084/jem.159.1.126. J Exp Med. 1984. PMID: 6607312 Free PMC article.
-
Arabinogalactan enhances Mycobacterium marinum virulence by suppressing host innate immune responses.Front Immunol. 2022 Aug 26;13:879775. doi: 10.3389/fimmu.2022.879775. eCollection 2022. Front Immunol. 2022. PMID: 36090984 Free PMC article.
-
In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.Clin Exp Immunol. 1990 Aug;81(2):319-24. doi: 10.1111/j.1365-2249.1990.tb03338.x. Clin Exp Immunol. 1990. PMID: 2387094 Free PMC article.
-
The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.Immunology. 1987 Jun;61(2):125-9. Immunology. 1987. PMID: 3496268 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources